Chiltern

Sacramento, United States Founded: 1986 • Age: 40 yrs Acquired By Chiltern International
Full-service oncology CRO operations are conducted globally.

About Chiltern

Chiltern is a Healthcare company based in Sacramento (United States) founded in 1986, and was acquired by Chiltern International in July 2014. Full-service oncology CRO operations are conducted globally. Chiltern has completed 1 acquisition, including Nexus Oncology. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Aster Insights, CancerVax and OnCusp; 3 of its 3 listed competitors have raised funding.

Company details

Ockham was a full-service oncology CRO with headquarters in North America and Europe and a presence in 12 countries in 4 continents. The company claims to have conducted 350 oncology-related Phase I-III clinical trials since its inception. Ockhams service portfolio included Scientific Affairs, Clinical Operations, Feasibility, Medical Affairs, Data Management and Biometrics. They catered to the needs of biopharmaceutical and medical device companies trying to develop oncology therapies. Ockham acquired Nexus Oncology, a 120 member strong UK-based oncology CRO, conducting Phase I-III oncology clinical trials across Europe, North America and Australasia in 2012. Post their acquisition by Chiltern, they offer their services through Chiltern Oncology, one of the 3 major divisions of Chiltern.

Key Metrics

Funding Insights of Chiltern

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $4.5M
  • First Round $4.5M

    (Jan 2012)

  • Investors Count 1

All 1 funding rounds of Chiltern with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2012$4.5MDebt – Conventional––
Valuation history

2 investors in total: 2 institutional.

Investors in Chiltern

Chiltern has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Chiltern International and Spring Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Flexible junior capital solutions are offered to growing businesses.
1999springcap.comLutherville, United States
Full service CRO with expertise in oncology related development services
1982chiltern.comBerkshire County, United States
Premium access

Investor details for Chiltern

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Chiltern

Chiltern has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nexus Oncology.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Specialist oncology clinical research services for drug trials were provided.
nexusoncology.comEdinburgh, United Kingdom1999Jan 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for Chiltern

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Chiltern

4 dated milestones of Chiltern across 28 years, from founding to its latest funding, stage changes and deals.

  1. Founded Chiltern is founded.
  2. Funding First funding round of $4.5M.
  3. Acquisition Acquires Nexus Oncology.
  4. Exit Acquired by Chiltern International.

Competitors of Chiltern

Chiltern has 3 listed competitors in our database, 3 of them funded. They include Aster Insights, CancerVax and OnCusp.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
asterinsights.com2006Tampa, United States$75M115
Contract-based oncology clinical trial services are provided by Aster Insights.
cancervax.com1998Carlsbad, United States$55M
Cancer vaccine research and development is conducted by CancerVax.
oncusptx.com2021New York, United States$100M
CRO offering clinical development services for oncology drugs
Premium access

Detailed competitors of Chiltern

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Chiltern

Websites that share an audience with Chiltern (ockham.com).

Similar websites

Websites whose visitors overlap most with Chiltern. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
novellaclinical.com
100%
View details
clinipace.com
96%
View details
medelis.com
88%
4.5K#4,216,660View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Chiltern (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Chiltern

Chiltern was founded in 1986 and raised its 1st funding round 26 years after it was founded.

Chiltern is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.

Ockham was a full-service oncology CRO with headquarters in North America and Europe and a presence in 12 countries in 4 continents. The company claims to have conducted 350 oncology-related Phase I-III clinical trials since its inception. Ockhams service portfolio included Scientific Affairs, Clinical Operations, Feasibility, Medical Affairs, Data Management and Biometrics. They catered to the needs of biopharmaceutical and medical device companies trying to develop oncology therapies. Ockham acquired Nexus Oncology, a 120 member strong UK-based oncology CRO, conducting Phase I-III oncology clinical trials across Europe, North America and Australasia in 2012. Post their acquisition by Chiltern, they offer their services through Chiltern Oncology, one of the 3 major divisions of Chiltern.

Chiltern's top competitors include CancerVax, OnCusp and Aster Insights.

Chiltern has made 1 acquisition, including Nexus Oncology.

Chiltern has 2 investors. Key investors include Chiltern International, and Spring Capital Partners.

Yes. Chiltern was acquired by Chiltern International in July 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available